Health
Body’s immune response drives production of non-functional COVID ‘gateway protein’: Study – Times of India
In the study, scientists, including those from the Francis Crick Institute in London, analysed existing genetic dat
Some immune system molecules trigger the production of a non-functional variant of the human protein used by the novel coronavirus to enter and infect host cells, according to a study that sheds light on the body’s natural defence against COVID-19. The research, published in the journal Nature Genetics, examined the genetic information that codes for the ACE2 receptor, to which the SARS-CoV-2 virus must bind in order to enter and infect human cells.
In the study, scientists, including those from…
-
Noosa News22 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General22 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
General11 hours agoDriver charged after fatal alleged hit-run crash at Hillier
-
General21 hours agoWoolworths executive was hospitalised by 100-hour-a-week workload, lawsuit claims